Diabetes and various other conditions might lead to complications such as unhealed chronic wounds (Shultz, G.S.; Wysocki, A., 2009). Chronic wounds are usually located on the inferior arts and adversely affect the quality of life because they can force patients to immobility and they feel constant pain.
Ulcers are skin wounds that are very hard to heal and have no or little healing/scarring process. The process of wound healing involves different molecular and biochemical pathways that regulate cell growth and differentiation and their management is still a critical clinical issue. Acute and chronic wounds that are hard to heal do not heal with standard therapies, such as medical dressing, negative pressure wound therapy and others.
Therefore, it becomes a priority to deal with the management of wounds to guarantee the patient an increased quality of life and a healing wound.
The Rigenera Technology consists of a minimally invasive procedure. The entire procedure occurs in one surgical time and lasts for about 30 minutes. The whole procedure can be managed in a private practice by a physician, who has received a dedicated training.
In an autologous, homologous and minimally invasive manner where the patient is both donor and acceptor.
The micrografts are obtained starting from small fragments of tissue harvested using a dermal punch, and then mechanically disaggregated with the Rigeneracons medical device. The processed tissue can be then used as micrografts.
Rigenera Technology is effective to treat the mentioned pathologies before they become even more difficult to manage by promoting an acceleration of wound healing process.
Fill the form, we will be glad to answer you as soon as possible
Over time, the number of scientific contributions about the applications of the Rigenera Technology to the field of Wound Care and Plastic Surgery has grown. Scientific papers represent a tangible testimony of the practical applications of Rigenera.
You can find out more about our: